Damoiseaux J, Jeyasekharan A D, Theunissen R, Tervaert J W Cohen
Department of Clinical and Experimental Immunology, University Hospital Maastricht, P. O. Box 5800, 6202 AZ Maastricht, the Netherlands.
Ann N Y Acad Sci. 2005 Jun;1050:163-9. doi: 10.1196/annals.1313.016.
Anticardiolipin antibodies (aCLAs) and antibodies to oxidized-low density lipoproteins (oxLDL) are associated with two distinct diseases: the antiphospholipid syndrome and atherosclerosis. Because both diseases may be apparent in patients with systemic lupus erythematosus (SLE), it is important to establish the relationship between these two types of antibodies. In the present study, we examined whether sera containing IgM and/or IgG aCLAs also react with LDL that has been oxidized by conjugation with malondialdehyde (MDA-LDL) or by incubation with copper ions (Cu-LDL). Results revealed a clear correlation between IgM aCLAs and IgM anti-MDA-LDL antibodies, and a weak correlation between IgG aCLAs and IgG anti-Cu-LDL antibodies. Cross-reactivity between both antibodies seemed to be limited. Because aCLAs are heterogeneous, only a minor subset of these antibodies may cross-react with oxLDL. Therefore, identification of both antibodies may be relevant for determination of the prognosis of accelerated atherosclerosis in SLE patients.
抗心磷脂抗体(aCLAs)和氧化型低密度脂蛋白(oxLDL)抗体与两种不同的疾病相关:抗磷脂综合征和动脉粥样硬化。由于这两种疾病在系统性红斑狼疮(SLE)患者中都可能出现,因此确定这两种抗体之间的关系很重要。在本研究中,我们检测了含有IgM和/或IgG aCLAs的血清是否也与通过与丙二醛(MDA-LDL)结合或与铜离子孵育(Cu-LDL)而被氧化的低密度脂蛋白发生反应。结果显示IgM aCLAs与IgM抗MDA-LDL抗体之间存在明显相关性,IgG aCLAs与IgG抗Cu-LDL抗体之间存在弱相关性。两种抗体之间的交叉反应似乎有限。由于aCLAs是异质性的,这些抗体中只有一小部分可能与oxLDL发生交叉反应。因此,同时检测这两种抗体可能对确定SLE患者加速动脉粥样硬化的预后具有重要意义。